The enrichment of immune cells, including macrophage M0, monocytes, B cells, CD8 T cells, CD4 T cells, follicular helper T cells, and natural killer cells in ‘High SHH’ tumors, underscores a more robust and diversified immune response, potentially enhancing the body’s ability to combat cancer. Here, CD4 is linked to cancer.